Biodetection, without compromise.

Revolutionizing biodetection with a patented nanobead technology for the multiplexed detection of high-precision biomarkers. Compatible with a variety of modalities, from rapid testing to high-resolution microscopic imaging for cancer diagnosis.
Discover more
Vega Bioimaging
Vega Bioimaging precision and accuracy

Unique Expertise for Unparalleled Specificity and Sensitivity

Vega BioImaging is a biodetection company at the forefront of innovation thanks to its patented nanotechnology. Our alloy nanoparticles enable quantitative and multiplexed detection of biomarkers, which can be used in contexts as varied as rapid tests or biopsies.

Enabling Reliable, Fast and Efficient Biodetection in Any Situation

Group 25

Our platform combines:

  • Innovative use of functionalized nanobeads
  • A wide range of tests, from rapid testing to ELISA and high-resolution microscopy
  • Sophisticated AI algorithms tailored for each test

To provide:

Quantitative, multiplexed, and highly sensitive detection of targeted biomarkers.

Vega Bioimaging
1.

Precision and Accuracy

Our gold-silver alloy nanoparticles offer unparalleled sensitivity and quantitative multiplexing, enabling precise detection of biological targets.

2.

Time Efficiency

Our technology reduces analysis times by enabling the simultaneous detection of several biomarkers on the same sample, thus accelerating decision-making, whether in the field of health or agriculture.

3.

Cost-Effective Solutions

By reducing the need for multiple tests and minimizing analysis errors, Vega BioImaging helps lower your costs while improving the efficiency of biodetection.

4.

Predictability

Thanks to an improved ability to predict the presence of pathogens or biomarkers of interest, our nanoparticles offer our customers a better understanding of their samples, allowing them better predictability.

5.

Support for the development of new targets

Vega BioImaging also offers development services for the creation of new tests. In particular, Vega collaborates with pharmaceutical companies to develop companion diagnostics (CDx), thereby optimizing drug development by identifying patient populations most likely to benefit from new therapies.

Learn more
Why Vega Bioimaging

Why Vega BioImaging ?

Why Vega Bioimaging
Vega BioImaging is a biodetection company at the forefront of innovation thanks to its patented nanotechnology. Our advanced detection kits enable quantitative and multiplexed detection of biomarkers, compatible with a wide variety of platforms. Our microscopy kits overcome the limitations of traditional immunohistochemistry (IHC) by offering increased sensitivity, stability, and accuracy for cancer subtyping and treatment response prediction.
Learn more about VEGA

Innovative Nanotechnology

Unlike traditional IHC and immunofluorescence, our patented nanobeads provide quantitative, multiplexed detection with higher stability and sensitivity, setting a new standard for cancer diagnostics.

AI Integration

Our advanced AI algorithms enhance the analysis of complex data sets, ensuring more accurate diagnostic interpretations and faster decision-making.

Highly Scalable

Vega BioImaging’s solutions are easily scalable, with a focus on reducing costs for pharmaceutical companies and healthcare systems through enhanced companion diagnostics.